FDA cell and gene therapy director exit increases ‘volatility’ for sector
Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week.
London Biotechnology Show 2025: Novo Nordisk harnesses AI/ML to accelerate drug development landscape
UK and US governments pursue contrasting vaccine strategies
Novartis’ ribociclib approved in Canada for early breast cancer
Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs
FDA Commissioner envisions fewer delays, more clinical trial flexibility and AI use
Analysis
View More
Themes
View MoreLisata collaborates with GATC Health on drug development
Lisata will utilise GATC's Multiomics Advanced Technology platform.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement
Are regulators keeping pace with AI adoption in clinical trials?